OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 15 citing articles:

ISTH guidelines for antithrombotic treatment in COVID‐19
Sam Schulman, Michelle Sholzberg, Alex C. Spyropoulos, et al.
Journal of Thrombosis and Haemostasis (2022) Vol. 20, Iss. 10, pp. 2214-2225
Open Access | Times Cited: 145

Arterial Thrombotic Events in Hospitalized COVID-19 Patients: A Short Review and Meta-Analysis
Matteo Candeloro, Sam Schulman
Seminars in Thrombosis and Hemostasis (2022) Vol. 49, Iss. 01, pp. 047-054
Open Access | Times Cited: 24

Autoimmunity and Immunodeficiency in Severe SARS-CoV-2 Infection and Prolonged COVID-19
Jenny Garmendia, Alexis García, Claudia Valentina De Sanctis, et al.
Current Issues in Molecular Biology (2022) Vol. 45, Iss. 1, pp. 33-50
Open Access | Times Cited: 24

Upper extremity deep vein thrombosis in COVID-19: Incidence and correlated risk factors in a cohort of non-ICU patients
Nicola Mumoli, Francesco Dentali, Giulia Conte, et al.
PLoS ONE (2022) Vol. 17, Iss. 1, pp. e0262522-e0262522
Open Access | Times Cited: 11

COVID-19 and comedications in atrial fibrillation—a case–control study in Stockholm
Max Bell, Anders Ekbom, Marie Linder
European Journal of Epidemiology (2023) Vol. 38, Iss. 3, pp. 301-311
Open Access | Times Cited: 3

D-dimer, BNP/NT-pro-BNP, and creatinine are reliable decision-making biomarkers in life-sustaining therapies withholding and withdrawing during COVID-19 outbreak
David M. Smadja, Benjamin A. Fellous, Guillaume Bonnet, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 5

Risks associated with prior oral anticoagulation use in hospitalized COVID-19 patients – A retrospective cohort study on 5392 patients from a tertiary centre
Petra Bistrović, Anica Sabljić, Ivona Kovačević, et al.
International Journal of Cardiology (2022) Vol. 372, pp. 144-149
Open Access | Times Cited: 4

Antithrombotic therapy in COVID-19 patients
Е. V. Slukhanchuk, В. О. Бицадзе, J. Kh. Khizroeva, et al.
Obstetrics Gynecology and Reproduction (2023) Vol. 16, Iss. 6, pp. 718-731
Open Access | Times Cited: 1

Venous thromboembolism in COVID-19
Naif Saad ALGhasab, Leen A. Altamimi, Mohammed Salem Alharbi, et al.
Saudi Medical Journal (2022) Vol. 43, Iss. 9, pp. 979-990
Open Access | Times Cited: 2

Platelet activation with the Aeson Bioprosthetic Total Artificial Heart: insight from aspirin treatment and outcomes
David M. Smadja, Christophe Peronino, Léa Jilet, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access

The 2023 Belgian clinical guidance on anticoagulation management in hospitalized and ambulatory COVID-19 patients
Thomas Vanassche, Matthias M. Engelen, Christelle Orlando, et al.
Acta Clinica Belgica (2023) Vol. 78, Iss. 6, pp. 497-508
Open Access

Heparin bei COVID-19: Standard- und Intermediärdosis im Vergleich

Gefäßmedizin Scan - Zeitschrift für Angiologie Gefäßchirurgie diagnostische und interventionelle Radiologie (2022) Vol. 9, Iss. 01, pp. 35-35
Closed Access

Covid-19 and comedications in atrial fibrillation – a case-control study in Stockholm
Max Bell, Anders Ekbom, Marie Linder
Research Square (Research Square) (2022)
Open Access

Page 1

Scroll to top